Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Coding Corner Question: February 2008

Staff  |  Issue: February 2008  |  February 1, 2008

A 46-year-old male with osteoarthritis of his right knee came in for a routine follow-up visit. The patient had intra-articular corticosteroid injection of his right knee six weeks ago, with reported improvement in knee pain and stiffness. The patient reports stiffness in the knee that lasts five to 10 minutes after long car rides and in the morning. This stiffness occurs once or twice a week. He also reports mild knee pain when climbing stairs. The patient has no other complaints or comorbidities. He is currently on etodolac and ranitidine as needed.

On examination, the patient had normal vital signs; height 5’10”, weight 190 pounds, body mass index 27.3. His lungs were clear. The heart’s regular rate and rhythm had no murmurs or friction rubs. The abdomen was soft, not tender, with no mass or hepatosplenomegaly. The right knee was crepitus and had mild knee tenderness on extreme of flexion, but no warmth or effusion. The left knee was unremarkable with full range of motion and no tenderness.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The diagnosis is clinically stable osteoarthritis of the right knee.

As treatment, the patient was given prescriptions to continue etodolac and ranitidine. He was counseled regarding benefits of daily exercise and weight loss in management of the osteoarthritis. Ways to incorporate daily physical activity into his schedule and recommendations on how to reduce fat and caloric intake were also discussed. The patient was asked to return in four months for a follow-up appointment, sooner if problems arise.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

What level of service is this patient encounter?

How would you code this? Click here for the answer.

Share: 

Filed under:Billing/CodingOsteoarthritis and Bone DisordersPractice Support Tagged with:Coding & BillingDiagnostic CriteriaOAOsteoarthritis

Related Articles

    Exercise Therapy Recommended to Manage Knee Osteoarthritis

    July 12, 2016

    The benefits of exercise therapy for individuals with knee osteoarthritis (OA) are well known. The ACR strongly recommends both aquatic exercise and land-based aerobic and resistance exercise for managing knee OA.1 A recent Cochrane systematic review and meta-analysis concluded that high-quality evidence supports the use of exercise to reduce pain and improve physical function and…

    Changing Our Thinking on Osteoarthritis

    March 1, 2010

    It’s time we changed our thinking on osteoarthritis

    Basics of Biologic Joint Reconstruction

    April 6, 2012

    For young patients especially, this can delay knee replacement and provide better outcomes.

    Baricitinib Studied as Possible COVID-19 Treatment; Plus Ranitidine Removed from U.S. Market

    May 11, 2020

    Baricitinib, an oral JAK1/JAK2 inhibitor approved to treat RA in adults, is being investigated as a possible treatment for hospitalized patients with COVID-19…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences